Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology

Area of Science:

• Neuro-oncology
• Genomics
• Bioinformatics

Background:

• Medulloblastoma and ependymoma are common pediatric central nervous system tumors.
• These tumors exhibit significant molecular and clinical heterogeneity, complicating diagnosis and treatment.

Purpose of the Study:

• To create a comprehensive reference gene expression landscape for medulloblastoma and ependymoma.
• To enable precise subtyping and identification of molecular biomarkers for these pediatric brain tumors.

Main Methods:

• Bulk RNA sequencing data from 888 medulloblastoma and 370 ependymoma tumors were analyzed.
• Rigorous data processing, including batch effect correction, normalization, and dimensionality reduction, was performed.
• A unified landscape was constructed to explore gene expression, pathways, gene fusions, and copy number variations.

Main Results:

• Distinct molecular subtypes were identified for ependymoma (EPN-E1, EPN-E2) with specific gene fusions.
• Medulloblastoma Group 3/4 tumors were precisely stratified by subtype, and SHH tumors by patient age.
• The developed landscape allows mapping of new patient data for accurate disease subtype identification.

Conclusions:

• The created landscape is a vital resource for biomarker discovery and refining diagnoses of pediatric brain tumors.
• The interactive Oncoscape platform facilitates global exploration and application of this reference framework.
• This work advances the understanding and classification of medulloblastoma and ependymoma.